pharmabiz.com Ranbaxy Group reported net sales of ¥185.4 billion, a growth of 5.7 per cent, on account of generic hypercholesteolemia treatment Atorvastatin after its launch in December 2011 and from generic anti-diabetic agent Pioglitazone, which Ranbaxy launched ...
PharmaTimes This has been achieved by the price dropping by more than 85% for new generics made by firms such as Teva, which have flooded the market since the launch of ...
Examiner.com Ranbaxy USA, Inc. has agreed to plead guilty to criminal information charging violations of the Food and Drug and Cosmetic Act and other criminal statutes i...
Business Standard DRL had launched 14 new products during the year, with the major contributors being finasteride 1mg (180-day exclusivity), montelukast granules, atorva...
Cancer Network Statins used by patients were atorvastatin , simvastatin, lovastatin, and pravastatin. Previous studies have suggested that statins may have an anti-canc...
The Herald | HeraldOnline.com 14 new products have been launched during the year, major contributors being finasteride 1mg (180 day exclusivity), montelukast granules, atorvastatin , metoprolol, clopidogrel, ibandronate and zoledronic acid 4mg/5mL. 19 product filings (18 ANDAs and 1 ... and more »
Equity Bulls Lost MS in generic Atorvastatin : RLL has lost MS in generic atorvastatin in the US after the voluntary recall of 40 lots from the US market. The company has re-launched the product and has ...
Pharmacy News Under the scheme, US patients seeking cheaper medications - mainly Lipitor ( atorvastatin calcium) and Celebrex (celecoxib) - sent their prescriptions to Canadian pharmacies, who then forwarded them to Australiawide Pharmacy in Watsons Bay. From 2005 ...
Business Standard The company had launched 14 new products during the year, with the major contributors being finasteride 1mg (180-day exclusivity), montelukast granules, atorvastatin , metoprolol, clopidogrel, ibandronate and zoledronic acid 4 mg/5ml. Finasteride ... and more »
Cardiovascular Business The company voluntarily recalled 10 mg, 20 mg and 40 mg dosage strengths of its atorvastatin calcium tablets packaged in 90- and 500-count bott...
